Your browser doesn't support javascript.
loading
Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol.
Schindler, Christoph; Birkenfeld, Andreas L; Hanefeld, Markolf; Schatz, Ulrike; Köhler, Carsta; Grüneberg, Martin; Tschöpe, Diethelm; Blüher, Matthias; Hasslacher, Christoph; Bornstein, Stefan R.
Afiliación
  • Schindler C; Clinical Research Center Hannover and Center for Pharmacology and Toxicology, Hannover Medical School, Hannover, Germany. schindler.christoph@mh-hannover.de.
  • Birkenfeld AL; Medical Clinic and Policlinic III at the University Hospital Dresden, Dresden, Germany.
  • Hanefeld M; Centre for Metabolic Vascular Medicine, GWT-TUD, Dresden, Germany.
  • Schatz U; Centre for Metabolic Vascular Medicine, GWT-TUD, Dresden, Germany.
  • Köhler C; Medical Clinic and Policlinic III at the University Hospital Dresden, Dresden, Germany.
  • Grüneberg M; Medical Consulting, GWT-TUD, Dresden, Germany.
  • Tschöpe D; Diabetes Center Herne, Herne, Germany.
  • Blüher M; Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
  • Hasslacher C; Department of Medicine at the University Hospital Leipzig, Leipzig, Germany.
  • Bornstein SR; Diabetesinstitut Heidelberg and Department of Clinical Studies, St. Josefskrankenhaus Heidelberg, Heidelberg, Germany.
Diabetes Ther ; 10(1): 329-331, 2019 02.
Article en En | MEDLINE | ID: mdl-30523582
ABSTRACT
In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetes Ther Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Diabetes Ther Año: 2019 Tipo del documento: Article País de afiliación: Alemania